Literature DB >> 17431505

Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage.

Ivan Luptak1, Mei Shen, Huamei He, Michael F Hirshman, Nicolas Musi, Laurie J Goodyear, Jie Yan, Hiroko Wakimoto, Hiroyuki Morita, Michael Arad, Christine E Seidman, J G Seidman, Joanne S Ingwall, James A Balschi, Rong Tian.   

Abstract

AMP-activated protein kinase (AMPK) responds to impaired cellular energy status by stimulating substrate metabolism for ATP generation. Mutation of the gamma2 regulatory subunit of AMPK in humans renders the kinase insensitive to energy status and causes glycogen storage cardiomyopathy via unknown mechanisms. Using transgenic mice expressing one of the mutant gamma2 subunits (N488I) in the heart, we found that aberrant high activity of AMPK in the absence of energy deficit caused extensive remodeling of the substrate metabolism pathways to accommodate increases in both glucose uptake and fatty acid oxidation in the hearts of gamma2 mutant mice via distinct, yet synergistic mechanisms resulting in selective fuel storage as glycogen. Increased glucose entry in the gamma2 mutant mouse hearts was directed through the remodeled metabolic network toward glycogen synthesis and, at a substantially higher glycogen level, recycled through the glycogen pool to enter glycolysis. Thus, the metabolic consequences of chronic activation of AMPK in the absence of energy deficiency is distinct from those previously reported during stress conditions. These findings are of particular importance in considering AMPK as a target for the treatment of metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431505      PMCID: PMC1847536          DOI: 10.1172/JCI30658

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

Review 1.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

2.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.

Authors:  A Subramaniam; W K Jones; J Gulick; S Wert; J Neumann; J Robbins
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

3.  Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase.

Authors:  K W Saupe; M Spindler; R Tian; J S Ingwall
Journal:  Circ Res       Date:  1998-05-04       Impact factor: 17.367

4.  Role of the AMP-activated protein kinase in the cellular stress response.

Authors:  J M Corton; J G Gillespie; D G Hardie
Journal:  Curr Biol       Date:  1994-04-01       Impact factor: 10.834

5.  Isolation and characterization of the mouse cardiac myosin heavy chain genes.

Authors:  J Gulick; A Subramaniam; J Neumann; J Robbins
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

6.  UDP-glucose pyrophosphorylase is upregulated in carriers of the porcine RN- mutation in the AMP-activated protein kinase.

Authors:  Jakob Hedegaard; Per Horn; René Lametsch; Hanne Søndergaard Møller; Peter Roepstorff; Christian Bendixen; Emøke Bendixen
Journal:  Proteomics       Date:  2004-08       Impact factor: 3.984

7.  Nonglucose substrates increase glycogen synthesis in vivo in dog heart.

Authors:  M R Laughlin; J Taylor; A S Chesnick; R S Balaban
Journal:  Am J Physiol       Date:  1994-07

8.  Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy.

Authors:  C R Malloy; A D Sherry; F M Jeffrey
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

9.  High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.

Authors:  N Kudo; A J Barr; R L Barr; S Desai; G D Lopaschuk
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

10.  Developmental regulation of myosin gene expression in mouse cardiac muscle.

Authors:  G E Lyons; S Schiaffino; D Sassoon; P Barton; M Buckingham
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  46 in total

1.  "AMPing up" our understanding of the hypothalamic control of energy balance.

Authors:  Kevin W Williams; Roberto Coppari; Joel K Elmquist
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  AMP-activated protein kinase regulation and biological actions in the heart.

Authors:  Vlad G Zaha; Lawrence H Young
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

Review 3.  Maternal cardiac metabolism in pregnancy.

Authors:  Laura X Liu; Zolt Arany
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

4.  Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome.

Authors:  Chang Xie; Ya-Ping Zhang; Lu Song; Jie Luo; Wei Qi; Jialu Hu; Danbo Lu; Zhen Yang; Jian Zhang; Jian Xiao; Bin Zhou; Jiu-Lin Du; Naihe Jing; Yong Liu; Yan Wang; Bo-Liang Li; Bao-Liang Song; Yan Yan
Journal:  Cell Res       Date:  2016-08-30       Impact factor: 25.617

5.  Physiological Expression of AMPKγ2RG Mutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice.

Authors:  Xiaodong Yang; John Mudgett; Ghina Bou-About; Marie-France Champy; Hugues Jacobs; Laurent Monassier; Guillaume Pavlovic; Tania Sorg; Yann Herault; Benoit Petit-Demoulière; Ku Lu; Wen Feng; Hongwu Wang; Li-Jun Ma; Roger Askew; Mark D Erion; David E Kelley; Robert W Myers; Cai Li; Hong-Ping Guan
Journal:  J Biol Chem       Date:  2016-09-12       Impact factor: 5.157

6.  AMP-dependent protein kinase activators: not just for diabetes?

Authors:  Heberty T F Facundo; Steven P Jones
Journal:  Circ Res       Date:  2009-02-13       Impact factor: 17.367

Review 7.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

8.  Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation.

Authors:  Simon A Hawley; Fiona A Ross; Cyrille Chevtzoff; Kevin A Green; Ashleigh Evans; Sarah Fogarty; Mhairi C Towler; Laura J Brown; Oluseye A Ogunbayo; A Mark Evans; D Grahame Hardie
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

Review 9.  iPS cell modeling of cardiometabolic diseases.

Authors:  Kenta Nakamura; Ken-ichi Hirano; Sean M Wu
Journal:  J Cardiovasc Transl Res       Date:  2012-10-16       Impact factor: 4.132

10.  Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction.

Authors:  Massimiliano Gnecchi; Huamei He; Luis G Melo; Nicolas Noiseaux; Fulvio Morello; Rudolf A de Boer; Lunan Zhang; Richard E Pratt; Victor J Dzau; Joanne S Ingwall
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.